ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:IBAB - BE0003766806 - Common Stock
12.1 EUR
-0.12 (-0.98%)
Overall IBAB gets a fundamental rating of 4 out of 10. We evaluated IBAB against 65 industry peers in the Health Care Equipment & Supplies industry. IBAB has a medium profitability rating, but doesn't score so well on its financial health evaluation. IBAB has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
IBAB had positive earnings in the past year.
IBAB had a positive operating cash flow in the past year.
Of the past 5 years IBAB 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: IBAB reported negative operating cash flow in multiple years.
1.2 Ratios
IBAB has a Return On Assets (2.71%) which is comparable to the rest of the industry.
IBAB's Return On Equity of 14.29% is fine compared to the rest of the industry. IBAB outperforms 80.00% of its industry peers.
IBAB has a Return On Invested Capital of 15.54%. This is amongst the best in the industry. IBAB outperforms 93.85% of its industry peers.
IBAB had an Average Return On Invested Capital over the past 3 years of 6.20%. This is below the industry average of 9.71%.
The 3 year average ROIC (6.20%) for IBAB is below the current ROIC(15.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROIC | 15.54% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
1.3 Margins
IBAB has a Profit Margin (2.85%) which is in line with its industry peers.
IBAB's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.48%, IBAB perfoms like the industry average, outperforming 44.62% of the companies in the same industry.
IBAB's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 31.21%, IBAB is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IBAB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBAB is creating value.
The number of shares outstanding for IBAB has been increased compared to 1 year ago.
The number of shares outstanding for IBAB has been reduced compared to 5 years ago.
IBAB has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.66, we must say that IBAB is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.66, IBAB is doing worse than 67.69% of the companies in the same industry.
A Debt/Equity ratio of 0.23 indicates that IBAB is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.23, IBAB is doing good in the industry, outperforming 66.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.66 |
ROIC/WACC2.15
WACC7.23%
2.3 Liquidity
IBAB has a Current Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
IBAB has a worse Current ratio (0.94) than 86.15% of its industry peers.
A Quick Ratio of 0.62 indicates that IBAB may have some problems paying its short term obligations.
IBAB has a worse Quick ratio (0.62) than 86.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 112.86% over the past year.
The Earnings Per Share has been growing slightly by 3.99% on average over the past years.
Looking at the last year, IBAB shows a quite strong growth in Revenue. The Revenue has grown by 15.96% in the last year.
The Revenue has been growing by 12.01% on average over the past years. This is quite good.
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
3.2 Future
Based on estimates for the next years, IBAB will show a very strong growth in Earnings Per Share. The EPS will grow by 58.72% on average per year.
The Revenue is expected to grow by 2.63% on average over the next years.
EPS Next Y151.4%
EPS Next 2Y108.36%
EPS Next 3Y67.72%
EPS Next 5Y58.72%
Revenue Next Year23.62%
Revenue Next 2Y13.14%
Revenue Next 3Y10.36%
Revenue Next 5Y2.63%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 21.23, which indicates a rather expensive current valuation of IBAB.
76.92% of the companies in the same industry are more expensive than IBAB, based on the Price/Earnings ratio.
IBAB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.61.
Based on the Price/Forward Earnings ratio of 11.55, the valuation of IBAB can be described as reasonable.
84.62% of the companies in the same industry are more expensive than IBAB, based on the Price/Forward Earnings ratio.
IBAB is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.01, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.23 | ||
| Fwd PE | 11.55 |
4.2 Price Multiples
IBAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IBAB is cheaper than 87.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.37 |
4.3 Compensation for Growth
IBAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IBAB's earnings are expected to grow with 67.72% in the coming years.
PEG (NY)0.14
PEG (5Y)5.33
EPS Next 2Y108.36%
EPS Next 3Y67.72%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.40%, IBAB has a reasonable but not impressive dividend return.
IBAB's Dividend Yield is a higher than the industry average which is at 1.03.
Compared to the average S&P500 Dividend Yield of 1.87, IBAB is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.4% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBAB pays out 8.05% of its income as dividend. This is a sustainable payout ratio.
DP8.05%
EPS Next 2Y108.36%
EPS Next 3Y67.72%
EBR:IBAB (12/23/2025, 5:29:59 PM)
12.1
-0.12 (-0.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap366.39M
Revenue(TTM)596.63M
Net Income(TTM)17.00M
Analysts80
Price Target14.62 (20.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.4% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.27%
PT rev (3m)-2.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.53%
EPS NY rev (3m)-18.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2%
Revenue NY rev (3m)1.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.23 | ||
| Fwd PE | 11.55 | ||
| P/S | 0.61 | ||
| P/FCF | N/A | ||
| P/OCF | 131.6 | ||
| P/B | 3.08 | ||
| P/tB | 3.88 | ||
| EV/EBITDA | 8.37 |
EPS(TTM)0.57
EY4.71%
EPS(NY)1.05
Fwd EY8.66%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.76%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.14
PEG (5Y)5.33
Graham Number7.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROCE | 25.19% | ||
| ROIC | 15.54% | ||
| ROICexc | 16.45% | ||
| ROICexgc | 19.79% | ||
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexgc growth 3YN/A
ROICexgc growth 5Y52.5%
ROICexc growth 3Y-88.2%
ROICexc growth 5Y50.32%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score7
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 65.94% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 5.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 1.66 |
F-Score7
WACC7.23%
ROIC/WACC2.15
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
EPS Next Y151.4%
EPS Next 2Y108.36%
EPS Next 3Y67.72%
EPS Next 5Y58.72%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
Revenue Next Year23.62%
Revenue Next 2Y13.14%
Revenue Next 3Y10.36%
Revenue Next 5Y2.63%
EBIT growth 1Y38.72%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year216.01%
EBIT Next 3Y67.42%
EBIT Next 5Y52.9%
FCF growth 1Y90.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y105.87%
OCF growth 3YN/A
OCF growth 5YN/A
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR.
What is the valuation status for IBAB stock?
ChartMill assigns a valuation rating of 6 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.
How profitable is ION BEAM APPLICATIONS (IBAB.BR) stock?
ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 5 / 10.
What is the valuation of ION BEAM APPLICATIONS based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ION BEAM APPLICATIONS (IBAB.BR) is 21.23 and the Price/Book (PB) ratio is 3.08.
What is the earnings growth outlook for ION BEAM APPLICATIONS?
The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 151.4% in the next year.